FDA Evaluating Reports of Side Effects of Ozempic, Mounjaro, and Wegovy on Hair Loss and Suicidal Thoughts
The US Food and Drug Administration (FDA) continues to evaluate reports about the side effects of medications such as “Ozempic,” “Mounjaro,” and “Wegovy” on hair loss, and suicidal thoughts among people who take them. These drugs, known as GLP-1 receptor agonists, to treat diabetes or weight loss, have been approved for use. They include semaglutide … Read more